These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 15952248)
1. Advances in prostate cancer research. Part II. Languino LR J Cell Biochem; 2004 Feb; 91(3):431-2. PubMed ID: 15952248 [No Abstract] [Full Text] [Related]
2. Biography: Dr Iain Frame, director of research, prostate cancer UK. Frame I; Maprayil S Expert Rev Anticancer Ther; 2014 Nov; 14(11):1261-4. PubMed ID: 25367320 [TBL] [Abstract][Full Text] [Related]
3. Advances in prostate cancer research and treatment. Livi L; Isidori AM; Sherris D; Gravina GL Biomed Res Int; 2014; 2014():708383. PubMed ID: 25215290 [No Abstract] [Full Text] [Related]
4. Advances in Prostate Cancer Research--AACR Special Conference In Cancer Research. Kuslak SL; Van Dyke T IDrugs; 2009 Mar; 12(3):159-62. PubMed ID: 19333894 [No Abstract] [Full Text] [Related]
5. [Attach importance to the research of criterion of treatment in prostate cancer]. Na YQ; Li M Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3169. PubMed ID: 16405831 [No Abstract] [Full Text] [Related]
6. Prostate Cancer Research at the Crossroads. Shen MM; Rubin MA Cold Spring Harb Perspect Med; 2019 Jul; 9(7):. PubMed ID: 30348836 [No Abstract] [Full Text] [Related]
7. Advances in Localized Prostate Cancer Management. Samadi DB; Feuerstein MA; Jazayeri SB; Kaplan SA; Farahat Y Biomed Res Int; 2018; 2018():2807813. PubMed ID: 29511674 [No Abstract] [Full Text] [Related]
8. The Prostate Cancer Foundation 16th Annual Scientific Retreat: meeting report. Rhodes KE; Simons JW; Soule HR Prostate; 2010 Jun; 70(8):916-20. PubMed ID: 20166134 [TBL] [Abstract][Full Text] [Related]
9. Treating prostate cancer, Part II: determining its severity. Harv Mens Health Watch; 2008 Jun; 12(11):1-4. PubMed ID: 18807624 [No Abstract] [Full Text] [Related]
10. The Center for Prostate Disease Research (CPDR): a multidisciplinary approach to translational research. Brassell SA; Dobi A; Petrovics G; Srivastava S; McLeod D Urol Oncol; 2009; 27(5):562-9. PubMed ID: 19720304 [TBL] [Abstract][Full Text] [Related]
11. Defeating prostate cancer: crucial directions for research--excerpt from the report of the Prostate Cancer Progress Review Group. Tindall DJ; Scardino PT Prostate; 1999 Feb; 38(2):166-71. PubMed ID: 9973103 [No Abstract] [Full Text] [Related]
16. Re: Post-treatment circulating plasma BMP6 mRNA and H3K27 methylation levels discriminate metastatic prostate cancer from localized disease. Zhu Y; Ye D Clin Chim Acta; 2010 Dec; 411(23-24):2117. PubMed ID: 20831865 [No Abstract] [Full Text] [Related]
17. Targeted local therapy in oligometastatic prostate cancer: a promising potential opportunity after failed primary treatment. Reeves F; Murphy D; Evans C; Bowden P; Costello A BJU Int; 2015 Aug; 116(2):170-2. PubMed ID: 25308065 [No Abstract] [Full Text] [Related]
18. [Current status and future perspectives of clinical research for prostate cancer]. Kakehi Y Nihon Rinsho; 2016 May; 74 Suppl 3():17-24. PubMed ID: 27344697 [No Abstract] [Full Text] [Related]
19. [Treatment of cancer of the prostate]. Vernet SG Ann Urol (Paris); 1970 Feb; 4(1):9-16. PubMed ID: 4194186 [No Abstract] [Full Text] [Related]
20. On Risk Estimation versus Risk Stratification in Early Prostate Cancer. Carlsson SV; Kattan MW PLoS Med; 2016 Aug; 13(8):e1002100. PubMed ID: 27482892 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]